-
公开(公告)号:US6001651A
公开(公告)日:1999-12-14
申请号:US45106
申请日:1998-03-20
IPC分类号: C12N15/09 , A61K31/711 , A61K38/00 , A61K39/00 , A61K48/00 , A61P1/00 , A61P19/02 , A61P29/00 , A61P31/00 , A61P35/00 , A61P37/06 , C07H21/04 , C12N15/113 , C12P19/34 , C12Q1/68 , C12N15/85 , C12N15/11 , C12P21/04
CPC分类号: C12N15/1138 , A61K38/00 , C12N2310/315 , C12N2310/3181 , C12N2310/321 , C12N2310/322 , C12N2310/334 , C12N2310/341 , C12N2310/346
摘要: Compositions and methods for the treatment and diagnosis of diseases or disorders amenable to treatment through modulation of expression of a nucleic acid encoding a lymphocyte function associated antigen 3 (LFA-3; also known as CD58) protein are provided.
摘要翻译: 提供了用于治疗和诊断易于通过调节编码淋巴细胞功能相关抗原3(LFA-3;也称为CD58)蛋白的核酸的表达进行治疗的疾病或病症的组合物和方法。